Have to agree with you. Looks like they are going for slow-paced growth. The news on Oraphyte was disappointing, but at least Schmeig didn't offer false hope for faster results. I have built up a position I am comfortable with in NVLX. I will now hold, don't plan on buying more any time soon.
Clearly, the market at large was not impressed with the data provided in the CC.